A Nature paper introduces PerturbFate, a platform that tracks how genetic changes reshape cell function and identifies key dependency points across a wide range of mutations.

Findings show that diverse mutations funnel into a common survival mechanism mediated by a mediator complex, with the VEGFC molecular signal acting as a central node for drug resistance and tumor growth.

To validate PerturbFate, researchers tested chemotherapy‑resistant melanoma cells by selectively disabling 143 genes and analyzing DNA accessibility and new RNA synthesis to map gene regulation.

Blocking VEGFC in melanoma cells caused rapid loss of drug resistance and halted tumor growth, demonstrating the potential for a universal treatment strategy targeting the tumor’s shared survival pathway.

The researchers suggest that future cancer therapies could focus on disrupting this shared mechanism rather than targeting each individual mutation, potentially improving outcomes for aggressive cancers.

A single common mechanism underpins hundreds of different cancer mutations, pointing to a universal target for therapy.